Lupin receives FDA approval for tablets to boost wakefulness

Baltimore-based Lupin Pharmaceuticals earned approval from the Food and Drug Administration for its armodafinil tablets.

Advertisement

According to a news release, the tablets are intended to improve wakefulness in adults with excessive sleepiness caused by various sleep disorders.

Armodafinil tablets are the generic equivalent of Cephalon’s Nuvigil tablets.

More articles on supply chain:

4 threats to the US blood supply
FDA approves Lanett’s muscle relaxant drug: 3 things to know
Addiction centers pay more than $700k to resolve allegations of improper prescribing

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.